Dyne Therapeutics, Inc. · NASDAQ:DYN
BlackRock, Inc. reported a 5.80% stake in Dyne Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 17, 2025
BlackRock, Inc. reported a 5.80% stake in Dyne Therapeutics, Inc., 6,577,879 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 6,577,879
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.80% | 6,577,879 |
Source
Related
- Dyne Therapeutics, Inc.
- BlackRock, Inc.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026